Determinants of RNA-Dependent RNA Polymerase (In)fidelity Revealed by Kinetic Analysis of the Polymerase Encoded by a Foot-and-Mouth Disease Virus Mutant with Reduced Sensitivity to Ribavirin
暂无分享,去创建一个
Armando Arias | J. Arnold | C. Cameron | E. Domingo | E. Smidansky | A. Arias | Esteban Domingo | Macarena Sierra | Eric D. Smidansky | Craig E. Cameron | Jamie J. Arnold | M. Sierra
[1] Guobin Luo,et al. Single-molecule and ensemble fluorescence assays for a functionally important conformational change in T7 DNA polymerase , 2007, Proceedings of the National Academy of Sciences.
[2] D. Olsen,et al. Nucleoside analog inhibitors of hepatitis C virus replication. , 2006, Infectious disorders drug targets.
[3] Smita S Patel,et al. Transient State Kinetics of Transcription Elongation by T7 RNA Polymerase*♦ , 2006, Journal of Biological Chemistry.
[4] M. Vignuzzi,et al. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population , 2006, Nature.
[5] C. Cameron,et al. Challenges for the Development of Ribonucleoside Analogues as Inducers of Error Catastrophe , 2004, Antiviral chemistry & chemotherapy.
[6] A. Thompson,et al. Stabilization of poliovirus polymerase by NTP binding and fingers-thumb interactions. , 2007, Journal of molecular biology.
[7] Julie K. Pfeiffer,et al. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[8] H. Mitsuya,et al. Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance , 2006, Cellular and Molecular Life Sciences.
[9] M. Götte. Inhibition of HIV-1 reverse transcription: basic principles of drug action and resistance , 2004, Expert review of anti-infective therapy.
[10] J. Arnold,et al. Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective☆ , 2004, Virus Research.
[11] Julie K. Pfeiffer,et al. Ribavirin Resistance in Hepatitis C Virus Replicon-Containing Cell Lines Conferred by Changes in the Cell Line or Mutations in the Replicon RNA , 2005, Journal of Virology.
[12] M. Vignuzzi,et al. Remote Site Control of an Active Site Fidelity Checkpoint in a Viral RNA-dependent RNA Polymerase* , 2005, Journal of Biological Chemistry.
[13] J. Arnold,et al. Nucleic Acid Polymerase Fidelity and Viral Population Fitness , 2008 .
[14] Bo Oberg. Rational design of polymerase inhibitors as antiviral drugs. , 2006, Antiviral research.
[15] E. Domingo,et al. The structure of a protein primer–polymerase complex in the initiation of genome replication , 2006, The EMBO journal.
[16] Marco Vignuzzi,et al. Engineering attenuated virus vaccines by controlling replication fidelity , 2008, Nature Medicine.
[17] E. Domingo,et al. Structure of Foot-and-Mouth Disease Virus RNA-dependent RNA Polymerase and Its Complex with a Template-Primer RNA* , 2004, Journal of Biological Chemistry.
[18] C. Cameron,et al. RNA virus error catastrophe: Direct molecular test by using ribavirin , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Arnold,et al. Poliovirus RNA-dependent RNA polymerase (3Dpol): kinetic, thermodynamic, and structural analysis of ribonucleotide selection. , 2004, Biochemistry.
[20] E. Domingo. Antiviral strategy on the horizon , 2005 .
[21] L. Loeb,et al. Viral error catastrophe by mutagenic nucleosides. , 2004, Annual review of microbiology.
[22] J. Arnold,et al. Poliovirus RNA-dependent RNA polymerase (3D(pol)). Assembly of stable, elongation-competent complexes by using a symmetrical primer-template substrate (sym/sub). , 2000, The Journal of biological chemistry.
[23] M. Wainberg,et al. Biochemical mechanisms involved in overcoming HIV resistance to nucleoside inhibitors of reverse transcriptase. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[24] L. Menéndez-Arias. Molecular basis of fidelity of DNA synthesis and nucleotide specificity of retroviral reverse transcriptases. , 2002, Progress in nucleic acid research and molecular biology.
[25] M. Lai,et al. Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase. , 2003, Biochemistry.
[26] Kenneth A. Brown,et al. Problems and Perspectives , 2009, The Search for Security in the Pacific 1901-1914.
[27] E. Domingo,et al. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. , 2003, Virology.
[28] E. Domingo,et al. Origin and Evolution of Viruses , 2010, Virus Genes.
[29] Identification of a Ribavirin‐resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy , 2003, Hepatology.
[30] V. Stollar,et al. Antiviral therapy targeting viral polymerase. , 2006, Current pharmaceutical design.
[31] T. Ahola,et al. Inhibitors of virus replication: recent developments and prospects , 2004, Applied Microbiology and Biotechnology.
[32] J. Arnold,et al. Poliovirus RNA-dependent RNA Polymerase (3Dpol) , 2000, The Journal of Biological Chemistry.
[33] C. Isel,et al. Nucleoside and nucleotide inhibitors of HIV-1 replication , 2006, Cellular and Molecular Life Sciences CMLS.
[34] Carroll Ss,et al. Nucleoside Analog Inhibitors of Hepatitis C Virus Replication , 2006 .
[35] C. Cameron,et al. Mechanisms of action of ribavirin against distinct viruses , 2005, Reviews in medical virology.
[36] J. Arnold,et al. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen , 2000, Nature Medicine.
[37] E. Domingo,et al. Mutant viral polymerase in the transition of virus to error catastrophe identifies a critical site for RNA binding. , 2005, Journal of molecular biology.
[38] A. Thompson,et al. Structural basis for proteolysis‐dependent activation of the poliovirus RNA‐dependent RNA polymerase , 2004, The EMBO journal.
[39] J. Arnold,et al. Poliovirus RNA-dependent RNA polymerase (3Dpol): pre-steady-state kinetic analysis of ribonucleotide incorporation in the presence of Mg2+. , 2004, Biochemistry.
[40] E. Domingo,et al. Sequential structures provide insights into the fidelity of RNA replication , 2007, Proceedings of the National Academy of Sciences.
[41] M. Kukhanova,et al. Design of anti-HIV compounds: from nucleoside to nucleoside 5'-triphosphate analogs. Problems and perspectives. , 2000, Current pharmaceutical design.
[42] J. Arnold,et al. Structure-function relationships among RNA-dependent RNA polymerases. , 2008, Current topics in microbiology and immunology.
[43] E. Domingo,et al. Foot-and-Mouth Disease Virus Mutant with Decreased Sensitivity to Ribavirin: Implications for Error Catastrophe , 2006, Journal of Virology.
[44] Julie K. Pfeiffer,et al. Increased Fidelity Reduces Poliovirus Fitness and Virulence under Selective Pressure in Mice , 2005, PLoS pathogens.
[45] M. Götte. Effects of nucleotides and nucleotide analogue inhibitors of HIV-1 reverse transcriptase in a ratchet model of polymerase translocation. , 2006, Current pharmaceutical design.
[46] Kenneth A. Johnson,et al. A new paradigm for DNA polymerase specificity. , 2006, Biochemistry.
[47] Jianping Ding,et al. Targeting HIV reverse transcriptase for anti-AIDS drug design: structural and biological considerations for chemotherapeutic strategies. , 1996, Drug design and discovery.